| CYTOKINETICS INC. DL-,001 |
| USA |
| Gesundheit |
| US23282W6057 / A1W1KK |
| KK3A (Frankfurt) / CYTK (NASDAQ) |
| FRA:KK3A, ETR:KK3A, KK3A:GR, NASDAQ:CYTK |
| - |
| https://cytokinetics.com/ |
|
Cytokinetics, Incorporated is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors. These small-molecule therapies target debilitating dise..
>Volltext.. |
| 9288.12 Mio. EUR |
| 9690.78 Mio. EUR |
| 92.64 Mio. EUR |
| -550.72 Mio. EUR |
| -726.31 Mio. EUR |
| -5.99 EUR |
| 1128.26 Mio. EUR |
| 116.4 Mio. EUR |
| -458.62 Mio. EUR |
| 4.13 |
| 415.57% |
| -26.26% |
| - |
| - |
| - |
| 4 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 5.699.698 Euro. |
| CYTOKINETICS |
| 03.07.26 |
|